Cartagena Protocol

Cartagena Protocol
Ciencias Españolas KoS · CC BY-SA 3.0 · source
Name	Cartagena Protocol on Biosafety
Caption	Logo of the Convention on Biological Diversity
Type	Multilateral environmental agreement
Signed	29 January 2000
Location signed	Cartagena, Colombia
Effective	11 September 2003
Parties	173 (as of 2024)
Depositor	Secretary-General of the United Nations

Cartagena Protocol is an international agreement addressing the transboundary movement of living modified organisms resulting from modern biotechnology. It supplements the Convention on Biological Diversity and establishes procedures for biosafety, risk assessment, and information exchange linked to the Nagoya Protocol, the Convention on International Trade in Endangered Species of Wild Fauna and Flora, and the Codex Alimentarius Commission deliberations. Negotiated amid debates involving World Trade Organization members, United Nations Environment Programme, and civil society groups such as Greenpeace and Friends of the Earth, it entered into force in 2003 and shaped subsequent biosecurity governance.

Background and Negotiation

Negotiations occurred against a backdrop of rapid advances in genetic engineering and public controversies after incidents like the StarLink corn episode and disputes under the Agreement on Sanitary and Phytosanitary Measures at the World Trade Organization. Delegations from Organisation for Economic Co-operation and Development members, developing country blocs such as the Group of 77, and regional organizations including the African Union and the European Union debated precautionary approaches advocated by NGOs and scientific bodies like the International Union for Conservation of Nature. High‑profile actors in the talks included ministers from Colombia, legal advisers from the United States Department of State, negotiators from Brazil and India, and technical experts from the Food and Agriculture Organization and World Health Organization.

Objectives and Scope

The protocol's primary aim is to ensure adequate protection in the field of transboundary movement, handling and use of living modified organisms (LMOs) that may have adverse effects on the conservation and sustainable use of biological diversity, with an emphasis on transboundary risks to Convention on Biological Diversity parties and the special consideration of indigenous and local community rights recognized in instruments such as the United Nations Declaration on the Rights of Indigenous Peoples. It applies to intentional transboundary movements of LMOs for introduction into the environment, while interactions with trade rules under the World Trade Organization and food safety frameworks involving the Codex Alimentarius are explicitly relevant to its scope.

Key Provisions and Obligations

The protocol establishes the Advance Informed Agreement procedure, requiring exporters to provide information before the first intentional transboundary movement of LMOs for release, and obliges importing parties to make decisions consistent with their domestic biosafety frameworks. Provisions mandate risk assessment and risk management guided by annexes influenced by technical guidance from bodies such as the Cartagena Protocol Compliance Committee and the Biosafety Clearing-House—a mechanism for sharing information modeled after systems like the Global Environment Facility information platforms. It recognizes the precautionary approach echoed in the Rio Declaration on Environment and Development and contains measures on liability and redress reflected in ongoing negotiations related to the International Law Commission work on state responsibility.

Implementation and Compliance Mechanisms

Implementation relies on national biosafety frameworks enacted by parties—including legislation inspired by examples from Canada, Australia, South Africa, and Mexico—and capacity-building support via the Global Environment Facility and technical assistance from the United Nations Development Programme and Japan International Cooperation Agency. Compliance is overseen through meetings of the Parties, subsidiary bodies, and a non‑judicial compliance mechanism whose functioning draws parallels with compliance procedures under the Montreal Protocol and the Kyoto Protocol frameworks. The Biosafety Clearing-House facilitates notification, risk assessment reports, and contact points, while dispute mechanisms interact with international dispute settlement practices in treaties like the United Nations Convention on the Law of the Sea.

Parties and Ratification

A broad coalition of states ratified the protocol, including major developing countries such as India, Brazil, and China as well as many European Union members; notable non-parties or late ratifiers have included the United States and Argentina at various stages. Ratification thresholds followed practices from instruments like the United Nations Framework Convention on Climate Change, leading to its entry into force in 2003 after the requisite number of instruments of ratification were deposited with the Secretary-General of the United Nations. Regional groups including the Pacific Islands Forum and the African Union coordinated positions during Conference of the Parties meetings.

Criticisms and Controversies

Critics from industry groups such as the Biotechnology Industry Organization argued that the protocol could create non‑tariff barriers to trade and conflict with World Trade Organization obligations. Environmental NGOs including Friends of the Earth and Greenpeace contended the measures were too weak on liability and lacked enforceable redress similar to norms promoted within the International Tribunal for the Law of the Sea context. Debates over the precautionary principle pitted positions upheld by the European Commission against risk‑based approaches favored by some United States Department of Agriculture and Australian Department of Agriculture representatives. Controversies also arose around the intersection with intellectual property norms under the Agreement on Trade-Related Aspects of Intellectual Property Rights and benefit‑sharing discussions linked to the Nagoya Protocol.

Impact and Case Studies

The protocol influenced national policies exemplified by biosafety laws in Kenya, Philippines, Mexico, and South Africa, and informed regional instruments such as the Cartagena Agreement-era trade dialogues in Mercosur and harmonization efforts in the European Union. Case studies include regulatory responses to field trials in Argentina and commercial releases in Brazil, emergency notifications for accidental transboundary movement akin to incidents addressed by International Civil Aviation Organization frameworks, and capacity‑building projects funded by the Global Environment Facility in Pacific island states like Fiji. Evaluations by bodies such as the United Nations Environment Programme and academic analyses in journals connected to Columbia University and University of California researchers have assessed its role in shaping biosafety governance, technology transfer, and debates over genetic resources in the twenty‑first century.

Category:International environmental law Category:Biotechnology regulation Category:Convention on Biological Diversity